Avoid Fraud, Get The Facts, And Find The Best
Legal Name: VIVO CAPITAL LLC
Period of report:
Jun 30, 2019
Effectiveness Date:
Aug 13, 2019
Security |
Shares Held / Principal Amount |
Market Value |
Option |
ASCENDIS PHARMA A S (04351P101)
|
2,060,135 |
$237,225k |
|
CRINETICS PHARMACE (22663K107)
|
3,375,169 |
$84,379k |
|
ARROWHEAD PHARMACEUT (04280A100)
|
2,765,153 |
$73,277k |
|
TRICIDA INC (89610F101)
|
1,424,525 |
$56,212k |
|
Codexis Inc (192005106)
|
2,614,458 |
$48,184k |
|
INSMED INC (457669307)
|
1,748,174 |
$44,753k |
|
Iovance Biotherapeutics Inc (462260100)
|
1,600,000 |
$39,232k |
|
SINOVAC BIOTECH LTD (P8696W104)
|
5,900,000 |
$38,173k |
|
ZYMEWORKS INC (98985W102)
|
1,453,467 |
$31,976k |
|
KALVISTA PHARMACEUTICALS (483497103)
|
1,359,149 |
$30,105k |
|
KADMON HOLDINGS INC (48283N106)
|
12,606,605 |
$25,970k |
|
MEDICINES CO (584688105)
|
669,012 |
$24,399k |
|
MENLO THERAPEUTICS (586858102)
|
4,011,236 |
$24,027k |
|
MIRATI THERAPEUTICS INC (60468T105)
|
233,045 |
$24,004k |
|
AMYRIS INC (03236M200)
|
6,490,557 |
$23,106k |
|
Homology Medicines (438083107)
|
1,159,742 |
$22,696k |
|
Eiger Biopharmaceuticals Inc (28249U105)
|
1,791,257 |
$18,987k |
|
ORCHARD THERAPEUTICS PLC (68570P101)
|
1,312,084 |
$18,356k |
|
CHIASMA INC (16706W102)
|
2,377,213 |
$17,758k |
|
CymaBay Therapeutics, Inc. (23257D103)
|
2,154,934 |
$15,429k |
|
MEI PHARMA INC (55279B202)
|
5,681,397 |
$14,203k |
|
XENON PHARMACEUTICALS INC (98420N105)
|
1,405,476 |
$13,858k |
|
AURINIA PHARMACEUTICALS INC (05156V102)
|
1,913,623 |
$12,592k |
|
SOLENO THERAPEUTICS INC COM (834203200)
|
4,268,959 |
$11,953k |
|
ROCKET PHARMACEUTICALS INC (77313F106)
|
786,712 |
$11,801k |
|
KINISKA PHARMACEUTIC (G5269C101)
|
843,478 |
$11,421k |
|
OBSEVA SA (H5861P103)
|
937,147 |
$10,599k |
|
NABRIVA THERAPEUTICS PLC SHS (G63637105)
|
4,039,139 |
$9,815k |
|
APELLIS PHARMACEUTICALS INC (03753U106)
|
383,538 |
$9,719k |
|
VERONA PHARMA PLC (925050106)
|
1,492,951 |
$7,614k |
|
GALMED PHARMACEUTICALS LTD (M47238106)
|
971,337 |
$7,139k |
|
DERMIRA INC (24983L104)
|
700,000 |
$6,692k |
|
Kala Pharmaceuticals, Inc. (483119103)
|
1,043,020 |
$6,654k |
|
KARUNA THERAPEUTICS INC (48576A100)
|
325,000 |
$6,507k |
|
MATINAS BIOPHARMA HLDG (576810105)
|
6,818,181 |
$5,840k |
|
ZOGENIX INC (98978L204)
|
105,000 |
$5,017k |
|
PRECISION BIOSCIENCES INC (74019P108)
|
280,511 |
$3,717k |
|
ACLARIS THERAPEUTICS INC (00461U105)
|
1,647,214 |
$3,607k |
|
GENOCEA BIOSCIENCES INC (372427401)
|
626,401 |
$2,455k |
|
DBV TECHNOLOGIES SA-SPON ADR (23306J101)
|
269,995 |
$2,219k |
|
AGILE THERAPEUTICS INC (00847L100)
|
1,513,975 |
$2,210k |
|
SIERRA ONCOLOGY INC (82640U107)
|
2,438,270 |
$1,365k |
|
SELECTA BIOSCIENCES INC (816212104)
|
546,054 |
$977k |
|
AKARI THERAPEUTICS PLC (00972G108)
|
345,850 |
$699k |
|
BioPharmX Corporation (09072X309)
|
317,270 |
$189k |
|
Soleno Therapeutics, Inc. - Warrant (834203135)
|
188,772 |
$19k |
|
Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.
All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.
Recently Searched Firms
Please note: Search data is accumulated by 3rd party and refreshed once per day.